Psioxus Therapeutics company

PsiOxus Therapeutics Ltd develops novel therapeutics for serious diseases with a particular focus upon cancer.
They are an Oxford based development stage biotechnology company with world leading scientists and a highly experienced management team.
Their approach is to combine macromolecular elements including viruses, polymers and other macro-molecules to produce novel patent protected therapeutics.
Technology: P4 Medicine
Industry: Regenerative Medicine
Headquarters: Abingdon, Oxfordshire, United Kingdom
Founded Date: 6-28
Employees Number: 51-100
Funding Status: N/A
Investors Number: 7
Total Funding: $102.5M
Estimated Revenue: $10M to $50M
Last Funding Type: Venture - Series Unknown

Visit Website
enquiries@psioxus.com
@Psioxus
Register and Claim Ownership